The Evidentia platform
Evidentia makes AI decisions provable. Every AI work product raises one question: what did the AI do, who approved it, and what evidence was it based on? Evidentia is Plexina's platform line built to answer it: AI evidence search, workflow analysis, and execution traceability. Clinical is one research lane, not the only one. The governance discipline is the same one Plexina proved over 21 years in healthcare.
This page is the corporate introduction. The full platform site (capabilities, health, trust) lives next door. We do not duplicate it here.
Proven and new. We say which is which
We tell you which is which. That is the same discipline, applied to how we talk about our own product.
What the platform does
Systematic, citable research modeled on systematic-review practice (PRISMA is one well-known form), run at machine speed, across research lanes, not only clinical. Every source checked for existence and citation integrity before it is cited.
A decomposition methodology that takes a described professional workflow and models it into a visible, optimizable structure, so institutional knowledge does not live only in one person's head.
From evidence to recommended action. Solution packages and impact assessment connect what the research found to what should change, and what that change affects.
Quality gates on every AI output and audit-complete traces, so the path from evidence to action is as defensible as the evidence itself.
First product on the platform
Veridok™ is an evidence-research assistant for individual researchers and small teams. Research that holds up to scrutiny.
Built within governance, not outside it
Every AI output moves through quality gates, expert review, and approval before it affects anything operational. Consequential steps cannot silently auto-approve in production. The person at the gate is the product as much as the gate is.
See it in use
Health order-set governance, Veridok research tools, and a catalog of engagements and designs, each labeled with an honest status.